Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes
NCT00940797Phase 2Completed
- Sponsor
- Laboratorios Silanes
- Start
- Jul 2008
- Primary completion
- Feb 2009
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Metformin glycinate in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Laboratorios Silanes. Primary endpoint: Insulin sensitivity at 2 months. Started Jul 2008; status: completed.
02
Drugs
Metformin glycinate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00940797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00940797.